November 2015 - Kinstellar is pleased to announce that its Life Sciences practice group in Prague has been ranked by LMG Life Sciences – a guide to the leading life sciences firms and attorneys in Europe and North America – among the top-tier law firms in the Czech Republic in the area of Life Sciences.
The Life Sciences practice group was further honoured as Lukáš Ševčík, Managing Partner, Květoslav T. Krejčí, Partner and Tomáš Čihula, Head of the practice group, were listed as recommended “star” individuals in this field. Kinstellar is the only law firm with three ranked, recommended lawyers for both transactions and regulatory issues in the area of Life Sciences in the Czech Republic, which demonstrates its unique market position and wide range of expertise.
Kinstellar has handled key maters in the Life Sciences area in the Czech Republic, including advising Novartis on local aspects of the swap of vaccine and oncology drug businesses; Mid Europa Partners on the acquisition of Euromedic’s laboratory network in the Czech Republic (an ad-on acquisition following the previous purchase of Alpha Medical, making it one of the largest private equity transactions in the past years); Dow on regulatory issues regarding plant protection products; and Bayer on the local aspects of the carve-out of Bayer Material Science into a separate subsidiary, Covestro (Germany’s largest IPO in more than eight years).
Kinstellar’s Life Sciences and Healthcare practice offers a full array of legal services in the area of pharmaceuticals, healthcare, biotechnology, medical devices, medical technology, diagnostics, chemicals, nutrition, agro-sciences and cosmetics. Kinstellar clients include primarily multinational and domestic companies and investors focused on these industries.
For more information please contact Lukáš Ševčík, Partner, at .